Daybreak Pharmaceuticals Inc.
Rockport, MA
- UEI
- C2DCR3EZ2SC3
- CAGE
- 0XNQ8
- SAM.gov registration
- Active through
Company facts
- Self-certified in SAM.gov
- Entity structure
- Corporate Entity (Not Tax Exempt)
- NAICS codes registered in SAM.gov
- SAM.gov registration date
- Physical address
- 4 Allen Ave, Rockport, MA 01966, USA
Registration and certifications come from SAM.gov and the SBA; company details from public web sources. Updated .
Recent federal awards
| Award | Agency | Obligated | Awarded |
|---|---|---|---|
| Enhancing chemotherapy efficacy by targeting the mutagenic translesion synthesis pathway - project summary… | National Cancer Institute | $303,345 |
Quick answers
What is Daybreak Pharmaceuticals Inc.'s UEI?
Daybreak Pharmaceuticals Inc.'s Unique Entity ID (UEI) in SAM.gov is C2DCR3EZ2SC3.
What is Daybreak Pharmaceuticals Inc.'s CAGE code?
Daybreak Pharmaceuticals Inc.'s CAGE code is 0XNQ8.
What is Daybreak Pharmaceuticals Inc.'s primary NAICS code?
Daybreak Pharmaceuticals Inc.'s primary NAICS code is 541714 (Research and Development in Biotechnology (except Nanobiotechnology)).
Where is Daybreak Pharmaceuticals Inc. located?
Daybreak Pharmaceuticals Inc.'s physical address in SAM.gov is 4 Allen Ave, Rockport, MA 01966, USA.
Is Daybreak Pharmaceuticals Inc. registered in SAM.gov?
Yes. Daybreak Pharmaceuticals Inc.'s SAM.gov registration is active through December 1, 2026.
What is Daybreak Pharmaceuticals Inc.'s most recent federal award?
Daybreak Pharmaceuticals Inc.'s most recent federal grant award is Enhancing chemotherapy efficacy by targeting the mutagenic translesion synthesis pathway - project summary… (R43CA310344), from National Cancer Institute, on September 1, 2026.
On GovTribe
See Daybreak Pharmaceuticals Inc.'s full federal record
- Federal grant awards
- Funding analysis by agency, NAICS and set-aside
- Similar vendors